SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-20-009717
Filing Date
2020-04-24
Accepted
2020-04-24 16:47:06
Documents
5
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10011271x2_defa14a.htm DEFA14A 41610
2 nc10011271x2_notice01.jpg GRAPHIC 1293778
3 nc10011271x2_notice02.jpg GRAPHIC 1671582
4 nc10011271x2_notice03.jpg GRAPHIC 757314
5 nc10011271x2_notice04.jpg GRAPHIC 377090
  Complete submission text file 0001140361-20-009717.txt   5688379
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36829 | Film No.: 20815694
SIC: 2834 Pharmaceutical Preparations